BioCentury
ARTICLE | Company News

Cozart, Spinreact S.A. deal

October 10, 2005 7:00 AM UTC

Immunodiagnostic company CZT acquired Spinreact for E13 million ($15.7 million) in cash. Spinreact sells diagnostics and reagents, and posted a pre-tax profit of E1.2 million ($1.4 million) on sales o...